Eric Sullivan - Dec 15, 2022 Form 4 Insider Report for TCR2 THERAPEUTICS INC. (TCRR)

Role
Chief Financial Officer
Signature
/s/ Margaret Siegel as Attorney-in-Fact
Stock symbol
TCRR
Transactions as of
Dec 15, 2022
Transactions value $
$0
Form type
4
Date filed
12/19/2022, 04:29 PM
Previous filing
Jun 27, 2022
Next filing
Jun 1, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TCRR Stock Option (Right to Buy) Award $0 +40.8K $0.00 40.8K Dec 15, 2022 Common Stock 40.8K $0.97 Direct F1
transaction TCRR Restricted Stock Unit (Right to Buy) Award $0 +6.8K $0.00 6.8K Dec 15, 2022 Common Stock 6.8K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on the one-year anniversary of the date of grant, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
F2 Each restricted stock unit represents a right to receive one share of the issuer's common stock at the time of vesting for no consideration.
F3 The restricted stock units will vest 25% on the one-year anniversary of the date of grant, with the remainder vesting in three equal annual installments thereafter.